Digi-Tech Pharma & AI 2026
27 May 2026 – 28 May 2026
Copthorne Tara Hotel London Kensington, London, United Kingdom
The 9th annual Digi-Tech Pharma & AI conference brings together pharmaceutical and technology leaders, healthcare innovators, regulators and solution providers to explore digital transformation in pharma. Topics include AI and machine learning in drug discovery, clinical trials, data science and big data, real-world data and evidence, digital health, and regulatory and ethical considerations. It is co-located with Global Clinical Trials Connect and hosted by Corvus Global Events.
35 sessions · 34 speakers
Organiser (1)
Sponsors (11)
Biorce · Baringa Partners LLP · WEP CLINICAL · Wiley · DexTrial Solutions · Deep Intelligent Pharma · MAASI Enterprises · Snaplogic · CiteAb · Gavion Technologies · Vertwo Advisory
Exhibitor (1)
Speakers (34)
- Konrad Dobschuetz Chief Strategy Officer, McGinley Orthopedics
- Bruce Hellman Co-Founder & Chief Patient Officer at uMotif, uMotif
- James Duboff Strategic Partnerships Director, Genomics England
- Esben Jannik Bjerrum Principal Research Scientist II, AI / ML Team Lead, AbbVie
- Murat Akturk Growth & Partnerships Leader, Corepany Yazılım Geliştirme Hizmetleri Ltd. Şti.
- Frederik Buijs Global Evidence Lead MS Franchise Integrated Evidence Planning, Roche
- Remco Loos Senior Director, Bristol Myers Squibb
- Olga Obrezanova Principal Scientist, Augmented Biologics Design, AstraZeneca
- Joubert Guelce VP of Clinical Solutions, Biorce
- Alireza Moayyeri Digital Transformation Lead RWE and Market Access, UCB
- Jordi Escayola Global Head Advanced Analytics, Artificial Intelligence & Data Science, Sanofi
- Michael Muehlberger Founder & CEO, SPACE44 GmbH
- Maria Palombini Global Practice Leader, Healthcare & Life Sciences, European Standards for Health Interoperability Alliance (ESHIA)
- Andrew Chalmers CEO, CiteAb
- Dominic Wellington Director of Product Marketing, SnapLogic
- Karina Morley Global Head Innovative Research & Strategic Alliances Biopharmaceutical Medical at Astrazeneca, AstraZeneca
- Danny Asher Bitton Principal Scientist - Head of Discovery Informatics, MSD
- Mohammad Hassan Khalid Head of AI/ML and Data Science, Portal Biotech
- Christof Jaeger Senior Director - Data Science & Modelling - Substance, Pharmaceutical Sciences, AstraZeneca
- Le (Muller) Mu Product Line Manager End-to-End AI&ML - MLOps Product Owner and Tech Lead, Roche
- Jenny Viklund Director, Team Leader Computational Chemistry, AstraZeneca
- Johann De Jong Data Science Lead, UCB
- Leandro Lo Cascio Head of Genomics, Medicines and Healthcare products Regulatory Agency
- Miriam Lopez Ramos Head of Data and AI Products for Research, Servier
- Vicent Benet Gil Executive Manager, SDG Group
- Sanjay Rathee AI Technical Lead, AstraZeneca
- Laura Von Schantz Senior Director, Antibody Discovery, Lundbeck
- Karla Viviani Allebrandt Privat Dozent, Boehringer Ingelheim Medicine
- Dafni Glinos Principal Data Scientist, Vertex Pharmaceuticals
- Carlo Russo IOT System Integrator, MAASI Enterprises
- Frank Dullweber Data Domain Owner - Governance & Insights in Clinical Development & Operations, Boehringer Ingelheim
- Tassnim Abdessalem Data Scientist, AstraZeneca
- Markus Heckenmuller Principal, Vertwo Advisory
- Stijn Janssen Business Analyst & SME HR Operations & Analytics, Philips
Agenda
- Welcome Address & Chairperson’s Opening Remarks 27 May 2026
- Enabling DMTA-Agents in Drug Discovery 27 May 2026
- Beyond the Hype: Practical GenAI in Drug Design 27 May 2026
- From Protocol Design to Operational Reality: Making Clinical Trials Work Before They Start 27 May 2026
- Accelerating Drug Discovery with AI: Breakthroughs, Challenges, and the Road Ahead 27 May 2026
- Predictive Science and Agentic AI Developments for Chemical Development 27 May 2026
- Introducing AI to antibody drug discovery - strategies to reduce the development risk 27 May 2026
- AI Pilots Work. So Why Don't They Scale? 27 May 2026
- A Technical approach to Right-Time Visibility and AI-Orchestrated OT Cybersecurity in Pharma Manufacturing 27 May 2026
- Building Agentic AI Systems Inside a regulated environment 27 May 2026
- Digital, Data, and AI: Transform to Scale in Pharma R&D 27 May 2026
- Federated Learning and (Gen) AI are Transforming how we Treat, Learn and Innovate in Healthcare 27 May 2026
- Benchmarking the Impact of AI in Biologics Discovery and Optimization for Pharma 27 May 2026
- Trust, Teach, Transform: Data Governance, Literacy & Sharing in the Age of AI 27 May 2026
- Panel Discussion: AI and Automation in Drug Discovery: From Hype to Real-World Breakthroughs – Can Innovation Keep Up with Regulation? 27 May 2026
- Automating Clinical Pharmacometric Model Development: From ML to Agentic AI 27 May 2026
- Regulatory science supporting standardisation in molecular diagnostics 27 May 2026
- Chairperson’s Closing Remark 27 May 2026
- Welcome Address & Chairperson’s Opening Remarks 28 May 2026
- The Invisible Trial: Merging Research into the Workflow of Care 28 May 2026
- Accelerating Translational R&D with Genomics 28 May 2026
- Three Success Stories: How To Accelerate Delivery Of Strategic Objectives 28 May 2026
- SMILES is All You Need - for Chemical Deep Learning in Drug Discovery 28 May 2026
- Accelerating Lab-in-a-Loop with Self-Service MLOps 28 May 2026
- Transparent Agentic AI for Evidence Discovery: Speed with Scientific Rigor 28 May 2026
- Accelerating evidence-based decision making in R&D: Connecting Strategy, Portfolio, and Evidence Across the Lifecycle 28 May 2026
- Reducing discovery timelines with LLM + MCP powered reagent selection 28 May 2026
- Panel Discussion: Advancing Drug Discovery and Patient Care: The Synergy of Emerging Technologies in Pharma-Health Collaboration 28 May 2026
- Foundation Models for Real‑World Patient Data: Representation Learning at Scale for Pharma R&D 28 May 2026
- Laying the foundations for data‑ and AI‑driven drug discovery: from lab digitalisation to AI‑augmented scientists 28 May 2026
- AI, Automation & LLM‑Powered Transformation: Concept to realization; High‑ROI Use Cases in Healthcare Sales and Service Optimization 28 May 2026
- Enhancing Clinical Trial Site Identification and Selection through Data Science and Predictive Analytics 28 May 2026
- Strategic Foresight: Architecting High-ROI AI Use Cases in Real-World Evidence Generation 28 May 2026
- Digital Tools, Real Risk: Securing Patient Safety and Clinical Trials Processes at the Edge 28 May 2026
- Chairperson’s closing remarks & End of Conference 28 May 2026